SCHEMBL23969675

SCHEMBL23969675

Clc1cc(CI)ccc1-c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 5/20 0.68
CYP2A6 P11509 1/20 0.48
CSNK2A2 P19784 2/20 0.42
CSNK2B P67870 2/20 0.42
CSNK2A3 Q8NEV1 2/20 0.42
MAOB P27338 2/20 0.41
RORC P51449 1/20 0.39
CXCR3 P49682 1/20 0.39
GRM2 Q14416 2/20 0.38
CCR2 P41597 1/20 0.38
FOLH1 Q04609 1/20 0.38
HTR1A P08908 1/20 0.38
HTR7 P34969 1/20 0.38
ESR1 P03372 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27709172 0.85 CSNK2A1 (0.68) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3
SCHEMBL3900981 0.82 CSNK2A1 (0.70) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3
SCHEMBL3912942 0.82 CSNK2A1 (0.70) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3
SCHEMBL17859694 0.81 CSNK2A1 (0.68) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3
SCHEMBL30440667 0.81 CSNK2A1 (0.68) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3
SCHEMBL30803440 0.81 CSNK2A1 (1.00) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3
SCHEMBL17859650 0.81 CSNK2A1 (0.68) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3
SCHEMBL27828640 0.78 CSNK2A1 (0.42) CSNK2A1FOLH1ALDH1A1HPGDTSHR
SCHEMBL29712509 0.78 CSNK2A1 (0.42) CSNK2A1FOLH1ALDH1A1HPGDHSD17B10
SCHEMBL7367797 0.78 CSNK2A1 (0.64) CSNK2A1CYP2A6CSNK2A2CSNK2BCSNK2A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102036937-A 2' -halobiphenyl-4-yl intermediates for the synthesis of angiotensin II antagonists LEK PHARMACEUTICALS 2011-04-27 CN claimed
CN-102015690-A Catalytic carboxylation in the synthesis of angiotensin II antagonists LEK PHARMACEUTICALS 2011-04-13 CN claimed
EP-3904366-A1 END CAPPED NUCLEIC ACID MOLECULES Novartis AG (CH) 2021-11-03 EP disclosed
CN-102036937-A 2' -halobiphenyl-4-yl intermediates for the synthesis of angiotensin II antagonists LEK PHARMACEUTICALS 2011-04-27 CN disclosed
CN-102015690-A Catalytic carboxylation in the synthesis of angiotensin II antagonists LEK PHARMACEUTICALS 2011-04-13 CN disclosed